AcouSort AB (publ) (STO:ACOU)
Sweden · Delayed Price · Currency is SEK 2.960
-0.020 (-0.67%)
At close: Mar 27, 2026
AcouSort AB Revenue
In the year 2025, AcouSort AB had annual revenue of 10.43M SEK with 4.01% growth. AcouSort AB had revenue of 2.82M in the quarter ending December 31, 2025, a decrease of -11.56%.
Revenue
10.43M
Revenue Growth
+4.01%
P/S Ratio
6.01
Revenue / Employee
652.00K
Employees
16
Market Cap
62.65M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10.43M | 402.00K | 4.01% |
| Dec 31, 2024 | 10.03M | -521.00K | -4.94% |
| Dec 31, 2023 | 10.55M | 1.97M | 22.90% |
| Dec 31, 2022 | 8.59M | 2.63M | 44.07% |
| Dec 31, 2021 | 5.96M | -864.00K | -12.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Magle Chemoswed Holding AB | 296.57M |
| Alzinova AB | 26.80M |
| Nanologica AB | 21.13M |
| Scandinavian ChemoTech AB | 12.29M |
| Biovica International AB | 10.93M |
| Spago Nanomedical AB | 4.82M |
| OncoZenge AB | 2.78M |
| Biosergen AB | 2.09M |